The detection of amplified products resulting from polymerase chain reactions (PCRs) remains a complicated process. To simplify the detection procedures, we developed a colorimetric microtiter plate hybridization assay for the specific detection of 5'-biotinylated PCR fragments ofMycobacterium leprae DNA. For this assay, an M. leprae DNA capture probe was made and immobilized on the wells of a microtiter plate. Hybridization of the biotin-labeled PCR fragments was detected through enzymatic color development. The resulting optical densities showed a logarithm-linear relationship with the amount of template DNA and corresponded to the intensity of the bands obtained through gel analysis and Southern blotting of the PCR products. The sensitivity of the assay was found to be 125 fg of genomic M. Ieprae DNA, or 20 lysed bacilli, revealing a detection limit similar to that of agarose gel analysis. The efficient coamplification of human DNA was used as a positive control for the presence of inhibitory substances in clinical material. For detection of human PCR products, a human DNA capture probe was also constructed for the colorimetric assay. This dual setup for hybridization, which thus detected both M. leprae and human DNA PCR products, was useful for ascertaining the presence of inhibiting substances in clinical specimens. All biopsy specimens (n = 10) from untreated patients with leprosy were positive. Apparently, this assay is more sensitive than microscopy, because biopsy specimens from half of the patients were negative upon histopathological examination. Biopsy specimens from three treated patients were negative, as were those from the three patients who did not have leprosy. We conclude that this colorimetric assay can replace agarose gel analysis and Southern hybridization, because it is as sensitive as those methods. Its advantages over conventional gel analysis and Southern hybridization are that it is less cumbersome and more rapid.
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Leprosy is still a major health problem in developing countries. Mycobacterium leprae, the causative organism of leprosy, cannot be grown in vitro and detection of the organism depends on the microscopic observation of acidfast bacilli, a technique which is not specific for M. leprae. Advances in new molecular techniques have offered the potential of a more sensitive and specific means of identifying pathogenic organisms and may enable detailed epidemiological studies (11, 16) . In particular, the polymerase chain reaction (PCR) promises to have a great impact on the improvement of the diagnosis of leprosy (3, 5, 18, 20) . Recently, we reported the development of a PCR for the specific detection of M. leprae; the PCR was based on the selective amplification of a 531-bp fragment of the prolinerich antigen (pra) gene (5) . That PCR was further developed for the detection of M. leprae in various biological specimens and was shown to be more sensitive than microscopy (3) .
For that PCR technique to be implemented as a tool in large studies, it is necessary that the hybridization procedure be easy to perform to ensure the specificity of the amplified DNA. We therefore decided to simplify the detection of amplified fragments, to circumvent the cumbersome procedure of gel electrophoresis and then Southern blotting with an M. leprae-specific probe (3, 5) . We chose to adapt a previously described colorimetric microtiter plate hybridization assay (9) for the simple detection of the 531-bp DNA fragments resulting from the amplification of M. leprae DNA. The advantage of the technique is that it requires equipment that is already used for enzyme-linked immunosorbent assays and that is readily available in many routine diagnostic laboratories. Furthermore, the technique has been shown to be comparable in sensitivity to Southern hybridization, but it is less labor-intensive and more rapid (7-9).
In the study described here, we investigated the usefulness of a colorimetric microtiter plate hybridization assay in comparison with agarose gel analysis and Southern hybridization for the detection of M. leprae and human DNA PCR fragments formed in a multiplex PCR by using biopsy specimens from patients with leprosy.
MATERIALS AND METHODS
Clinical specimens. Skin biopsy specimens from 10 untreated patients with leprosy, 3 patients at the end of their 24 months of multiple-drug treatment (MDT), and 3 patients with skin diseases other than leprosy were collected and quickly frozen in liquid nitrogen. Classification of leprosy was based on the enumeration of acid-fast bacilli in skin biopsy specimens expressed as the bacterial index of the granuloma on sections stained by the modified Fite method (15) (21) , and the concentration of bacilli was measured by determining the OD at 420 nm (17) . Tenfold Immobilization of the capture probe. We used the method of noncovalent attachment of the capture probe to microtiter wells essentially as described by Nagata et al. (14) . The M. Ieprae and human DNA capture probes were dissolved in water to make a stock solution (500 p,g/ml). For (Fig. 2) . As illustrated in Fig. 2A, theOD (Fig. 2B ). As shown in Fig. 2C , the detection limit of the assay was reached when 20 lysed bacilli were used as the source of template DNA; agarose gel analysis revealed the same detection limit (Fig. 2D) .
The results obtained by the colorimetric assay were compared with those obtained by the traditional Southern hybridization technique. For that comparison, the amplified material of a serial dilution of purified M. leprae DNA was subjected to PCR and the resulting products were used in both assays. The resulting ODs and integrated ODs were significantly correlated (Pearson correlation coefficient r = 0.987; P < 0.01).
The reproducibility of the colorimetric assay was determined by assessing both between-run and within-run variations. The between-run variation was examined by testing independently amplified samples containing the same amount of M. leprae template DNA (6.25 pg) and adding each resulting PCR product to a different well in the colorimetric microtiter plate hybridization assay. The mean OD thus obtained was 0.275 + 0.030 (n = 20), giving a betweenrun variation of 10.9%. The within-run variation was determined by adding the PCR product from one mixture, derived from 6.25 pg of template DNA, to different wells in the colorimetric assay. The mean OD was 0.267 + 0.017 (n = 20), giving a within-run variation of 6.4%. The between-run and within-run variations of the microtiter assay with the human DNA capture probe and PCR products derived from human template DNA (25 ng) were assessed in the same way. The between-run and within-run variations were 8.3 and 2.6%, respectively.
To assess the usefulness of the assay in laboratory practice, it is a prerequisite to know the influence of the presence of human DNA on the amplification efficiency of M. leprae DNA when testing human specimens. Therefore, human placental DNA was coamplified in the same tube as purified M. leprae DNA under the standardized M. leprae PCR conditions. Tenfold serial dilutions of M. leprae DNA (625 pg to 62.5 fg) were amplified in the absence and presence of 25 ng of human placental DNA (corresponding to 3,750 diploid cells). The resulting PCR products were analyzed in the colorimetric assay and by gel electrophoresis (Fig. 3) . In addition, M. leprae DNA (6.25 pg) was amplified in the presence of various amounts of human placental DNA ranging from 250 pg to 2.5 ,ug, which is equivalent to 38 to 375,000 diploid cells (Fig. 3B) . Agarose gel analysis showed that there was no cross-reactivity when using both primer sets in one PCR mixture (Fig. 3B) . Furthermore, both experiments showed that the detection limit of theM. leprae PCR products was not influenced by the presence of human DNA. Although the presence of human DNA in the M. leprae PCR caused a slight decrease in the overall intensity of the signals obtained by both agarose gel and colorimetric analyses (Fig. 3) , this observation was independent of the amount of human DNA present in the PCR mixture ( Fig. 3C and D).
Thirteen skin biopsy specimens from 10 untreated patients with leprosy and 3 patients with leprosy at the end of their MDT and biopsy specimens from 3 patients with skin diseases other than leprosy were examined by the multiplex PCR. The resulting PCR products were tested in the colorimetric microtiter plate hybridization assay described above; the results were compared with those obtained in the gel firmed by agarose gel analysis. In addition, in the samples derived from the patients who did not have leprosy, no M. leprae PCR fragment could be detected after agarose gel analysis. These negative PCR results could not be explained by inhibitory factors in the PCR mixtures, because the human internal control PCR fragment could be visualized in the gel when any of these specimens was used. The ODs obtained by the colorimetric assay were in agreement with agarose gel analysis results (Table 1 ). Higher ODs were found when biopsy specimens from untreated patients were used than when those from treated patients were used. The ODs obtained for control biopsy specimens from patients who did not have leprosy were all negative. By using the colorimetric assay with the human DNA capture probe, 268-bp PCR products could be detected in all specimens, which was in agreement with the results of agarose gel analysis. DISCUSSION PCR holds promise as a sensitive and specific system for the detection of M. leprae in a variety of specimens (3). Wide-scale application of this technology in routine diagnostic laboratories requires that the procedures be simple and reproducible (16) . This need is addressed by the colorimetric microtiter plate hybridization assay for the detection of amplified M. leprae DNA described in this report.
The hybridization step in the assay allows specific detection of amplified M. leprae DNA and is not dependent on the use of radioisotopes. The specificity of the hybridization reaction was illustrated by the fact that amplified M. leprae DNA hybridized only to the M. leprae DNA capture probe but not to the human DNA capture probe or to the singlestranded DNA of M13BM21. Similar findings have been reported by others using the M13 capture probe system for the detection of amplified DNA of viral origin (9, 10) .
The sensitivity of the colorimetric assay was shown to correspond to that of agarose gel analysis. Both had a detection limit of 125 fg of amplified DNA derived from purified M. leprae template DNA, which is equivalent to 25 bacilli, given that the size of the M. leprae genome is 2.2 x 109 Da (2) . This corresponded to the detection limit of the colorimetric assay when we used template DNA derived from lysed bacilli. Other investigators (6, 13) , who used similar detection assays, have reported that they could detect 10 to 13 copies of target DNA, which is the same range that we found. The addition of various amounts of human placental DNA slightly decreased the sensitivity of the assay in detecting M. leprae. Thus, the coamplification of human DNA had only a minimal effect on the detection of small amounts of template DNA, as was the case in a PCR for viral DNA (10) . These findings suggest that reproducible amplification can be measured in the presence of various amounts of human DNA.
The significant correlation between the ODs from the colorimetric assay and the integrated ODs from Southern hybridization implies that the results of the colorimetric assay truly reflect the amount of specifically amplified PCR negative control samples used in the colorimetric assay were the PCR samples which contained no M. leprae DNA or human DNA. These were added to the wells coated with the M. leprae DNA capture probe and the human DNA capture probe, respectively. The resulting ODs were always lower than the cutoff value.
fragments. In addition, the logarithm-linear relationship between the amount of template DNA (20 to 2 x 105 bacilli) and the OD of the colorimetric assay (Fig. 2) suggests that the assay could be used semiquantitatively to assess the relative amount of M. leprae DNA in a sample. Other investigators (6, 13, 19) have indeed reported the use of similar colorimetric assays which were linear over a range of 1 x 102 to 5 x 104 copies of template DNA. Since logarithmlinear relationships can be observed by different assays, colorimetric detection of the PCR products might be useful for semiquantification.
When the reproducibility of the colorimetric microtiter plate hybridization assay was tested, it showed a variation of 10.9%. This is similar to the performance of other nonisotopic assays, which have been reported to show variabilities of between 10 and 14% (4, 6, 13) . The within-run variation was lower than the between-run variation. This was most likely because the latter includes the variation of the PCR in addition to that of the colorimetric assay. Capture probecoated microtiter plates were shown to be stable for at least 12 weeks at room temperature; the variation for different times of storage did not exceed the between-run variation. These results suggest that the colorimetric microtiter plate hybridization assay described here would be useful in routine diagnostic laboratories.
We demonstrated the utility of the colorimetric assay using biopsy specimens from patients with leprosy. All biopsy specimens from untreated MB and PB patients were positive in the assay, which was in concordance with the results of agarose gel analysis. One sample (sample 4, Table  1 ), however, revealed low ODs in the colorimetric assay when either the M. leprae or the human DNA capture probe was used. This suggests the presence of PCR-inhibiting substances in this sample, a phenomenon which we have previously reported in a PCR with unpurified biopsy specimens (3) . PCR positivity in specimens in which no acid-fast bacilli can be detected by microscopy has been reported (3); it likely is due to the higher sensitivity of the PCR-based technology. The specimens from the patients who had received MDT were negative. These results are in accordance with previous findings (3), and considering the semiquantitative nature of the assay, these results are suggestive of the possible usefulness of nucleic acid amplification techniques for monitoring the bacillary load of patients with leprosy during MDT. In conclusion, the colorimetric microtiter plate hybridiza- tion assay described here is a method for the sensitive and specific detection of M. leprae DNA. The results of the assay with a limited number of clinical specimens described here are encouraging and will allow us to perform larger studies, which are required to determine the actual sensitivity and specificity of the assay. The assay is simple, rapid, and reproducible. The hybridization step involved in the assay ensures that the correct PCR product is produced. An additional advantage is that it yields numerical data and thus does not depend on subjective interpretation. Furthermore, the assay does not require radioisotopes, making its implementation in routine diagnostic laboratories a feasible prospect.
